How is gene therapy transforming the treatment of pediatric retinal diseases ? And, what could it teach us about myopia and eye growth?
During the 2026 Congress of the French Society of Ophthalmology (SFO), Prof. Alejandra Daruich, ophthalmologist at Necker-Enfants Malades University Hospital (Paris, France), discusses the latest advances in gene therapy for inherited retinal diseases, including:
- Gene therapy outcomes for RPE65-associated retinal dystrophy and its impact on visual outcomes in children
- Key challenges in gene therapy: gene delivery, treatment safety, long-term efficacy, accessibility, and the complexity of inherited retinal diseases
- How advances in retinal biology could reveal new insights into how the retina regulates eye growth and visual development
- What these molecular pathways could mean for the future of myopia research, prevention, and treatment
Could a better understanding of retinal gene therapy open new perspectives for pediatric myopia management?
Discover the key insights in this interview.
